You've used all available free searches this month | for more free features.

Small Cell Lung

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

Recruiting
  • Untreated Advanced Non-small Cell Lung Cancer
  • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Nov 13, 2023

TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

Not yet recruiting
  • Lung Cancer, Non-small Cell
  • Small Cell Lung Cancer
    • (no location specified)
    Nov 16, 2022

    Identify Resected Non-small-cell Lung Cancer With High Risk of

    Recruiting
    • Non-small Cell Lung Cancer Stage IIIA
    • Resected non small cell lung cancer
    • Toulouse, France
      Julien MAZIERES
    Feb 8, 2023

    NSCLC Trial in Omaha (PLB1004)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • Omaha, Nebraska
      Nebraska Cancer Specialists
    Sep 19, 2023

    NSCLC Trial in Guangzhou (BL-M07D1)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Nov 1, 2023

    NSCLC Trial (Tislelizumab IV, Tislelizumab SC, Histology-Based Chemotherapy Doublet)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Tislelizumab IV
    • +2 more
    • (no location specified)
    Oct 25, 2023

    Participation for Small Cell Lung Cancer Patients

    Not yet recruiting
    • Small Cell Lung Cancer
      • (no location specified)
      Mar 3, 2023

      Integrative Multi-Omics Testing for Immunotherapy Response in

      Recruiting
      • Lung Cancer
        • Guangzhou, Guangdong, China
          Nanfang hospital
        Jun 29, 2023

        Non Small Cell Lung Cancer Metastatic Trial (MRI)

        Not yet recruiting
        • Non Small Cell Lung Cancer Metastatic
        • MRI
        • (no location specified)
        May 16, 2023

        NSCLC Trial in Houston (Amivantamab, Tepotinib)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Houston, Texas
          MD Anderson Cancer Center
        Oct 9, 2023

        Immune-Connected Assays in Small Cell Lung Cancer

        Recruiting
        • Small Cell Lung Cancer
        • Rome, Italy
          Fondazione Policlinico Gemelli IRCCS
        Apr 2, 2023

        NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)

        Recruiting
        • Carcinoma, Non-Small-Cell Lung
        • Wuhan, Hubei, China
          Qian Chu
        Aug 18, 2023

        NSCLC, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation Trial in Fairfax (STX-721)

        Not yet recruiting
        • Non-Small Cell Lung Cancer
        • +2 more
        • Fairfax, Virginia
          NEXT Virginia
        Sep 18, 2023

        Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

        Not yet recruiting
        • Limited Stage Lung Small Cell Carcinoma
        • +3 more
        • Nashville, Tennessee
          Vanderbilt University/Ingram Cancer Center
        Nov 10, 2023

        Advanced NSCLC Trial in Jinan (almonertinib)

        Recruiting
        • Advanced Non-small Cell Lung Cancer
        • Jinan, Shandong, China
          Degan Lu
        Sep 12, 2023

        Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for

        Not yet recruiting
        • Limited-stage Small Cell Lung Cancer (LS-SCLC)
        • Tifcemalimab injection
        • +3 more
        • Jinan, Shandong, China
          Shandong Cancer Hospital & Institute
        Oct 18, 2023

        Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

        Recruiting
        • Non Small Cell Lung Cancer
        • +2 more
        • Port Saint Lucie, Florida
        • +1 more
        Aug 11, 2023

        Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)

        Recruiting
        • Non-Small-Cell Lung Cancer
        • Guangzhou, Guangdong, China
          Guangdong General Hospital
        Aug 25, 2023

        Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)

        Not yet recruiting
        • Non Small Cell Lung Cancer
        • Propranolol
        • Propranolol hydrochloride
        • +2 more
        • (no location specified)
        Jul 31, 2023

        Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

        Recruiting
        • Nonsmall Cell Lung Cancer
        • HS-10365 capsules
        • Shanghai, Shanghai, China
          Shanghai Chest Hospital
        Nov 22, 2023

        Advanced Non-small-cell Lung Cancer Trial in Shanghai (AK112, AK104, caboplatin)

        Not yet recruiting
        • Advanced Non-small-cell Lung Cancer
        • Shanghai, China
          Shanghai Pulmonary Hospital
        Jun 6, 2023

        NSCLC, NSCLC Trial in Guangzhou (Apatinib + Fluzoparib, Apatinib + Fluzoparib + Adebrelimab)

        Not yet recruiting
        • NSCLC
        • Non-small Cell Lung Cancer
        • Apatinib + Fluzoparib
        • Apatinib + Fluzoparib + Adebrelimab
        • Guangzhou, Guangdong, China
          Sun Yat-Sen University Cancer Center
        Jun 27, 2023

        Examination of Trends in Non-Small Cell Lung Cancer Patients'

        Not yet recruiting
        • Non-Small Cell Lung Cancer
          • (no location specified)
          Mar 10, 2023

          Metabolic Response to Food in Advanced Lung Cancer

          Not yet recruiting
          • Carcinoma, Non-Small-Cell Lung
          • Weight loss (%)
          • (no location specified)
          Jun 30, 2023

          NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

          Not yet recruiting
          • Non-Small Cell Lung Cancer
          • Crizotinib - Usual
          • Crizotinib - Study
          • Rockville, Maryland
            Medicine Invention Design, Inc. - IORG0007849
          Oct 5, 2023